Celltrion targets $3.46 bn in sales this year on biosimilarsby The Uttam Hindu 18 March 2025 3:52 PM IST
Celltrion targets $3.46 bn in sales this year on biosimilarsby The Uttam Hindu 18 March 2025 10:22 AM IST
S.Korean drugmaker Celltrion gets USFDA approval for allergic asthma biosimilarby The Uttam Hindu 10 March 2025 1:56 PM IST
Celltrion's autoimmune disease treatment gets approval in Europeby The Uttam Hindu 24 Feb 2025 11:08 AM IST
Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatmentby The Uttam Hindu 31 Jan 2025 2:47 PM IST
Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatmentby The Uttam Hindu 31 Jan 2025 1:19 PM IST
Celltrion's autoimmune disease treatment hits 5 major European countriesby The Uttam Hindu 23 Jan 2025 12:06 PM IST
S. Korea fines pharma giant Celltrion for unfair business practicesby The Uttam Hindu 3 Dec 2024 1:21 PM IST
S. Korean drugmaker Celltrion to buy back its shares for 4th time in 2024by The Uttam Hindu 25 Oct 2024 11:34 AM IST
